tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PULM Stock Latest News

Pulmatrix trading resumes
The FlyPulmatrix trading resumes
10d ago
PULM
Pulmatrix and Cullgen Announce Strategic Merger Agreement
PremiumCompany Announcements
Pulmatrix and Cullgen Announce Strategic Merger Agreement
10d ago
8K
PULM
Pulmatrix announces merger agreement with Cullgen
PremiumThe Fly
Pulmatrix announces merger agreement with Cullgen
10d ago
PULM
Pulmatrix trading halted, news pending
PremiumThe Fly
Pulmatrix trading halted, news pending
10d ago
PULM
Pulmatrix reports Q3 EPS (71c) vs. ($1.03) last year
PremiumThe Fly
Pulmatrix reports Q3 EPS (71c) vs. ($1.03) last year
15d ago
PULM
Pulmatrix sees cash runway into 4Q26
PremiumThe FlyPulmatrix sees cash runway into 4Q26
15d ago
PULM
Pulmatrix reports Q2 EPS ($1.59) vs. ($1.04) last year
Premium
The Fly
Pulmatrix reports Q2 EPS ($1.59) vs. ($1.04) last year
3M ago
PULM
Pulmatrix Announces Executive Changes and New Interim CEO
Premium
Company Announcements
Pulmatrix Announces Executive Changes and New Interim CEO
4M ago
8K
PULM
MannKind to in-license iSPERSE technology from Pulmatrix
PremiumThe Fly
MannKind to in-license iSPERSE technology from Pulmatrix
6M ago
MNKD
PULM
Pulmatrix enters cross license agreement with MannKind
PremiumThe Fly
Pulmatrix enters cross license agreement with MannKind
6M ago
MNKD
PULM
Pulmatrix files $95M mixed securities shelf
PremiumThe Fly
Pulmatrix files $95M mixed securities shelf
6M ago
PULM
Pulmatrix announces results from PUR3100 study
PremiumThe Fly
Pulmatrix announces results from PUR3100 study
6M ago
PULM
Pulmatrix Publishes Study on Inhalable Migraine Treatment
PremiumCompany AnnouncementsPulmatrix Publishes Study on Inhalable Migraine Treatment
6M ago
8K
PULM
Pulmatrix reports Q1 EPS 23c vs ($1.22) last year
Premium
The Fly
Pulmatrix reports Q1 EPS 23c vs ($1.22) last year
7M ago
PULM
PULM Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
PULM Earnings this Week: How Will it Perform?
8M ago
PULM
Pulmatrix Shifts to Outsourced CMO Model, Terminates Executive
PremiumCompany Announcements
Pulmatrix Shifts to Outsourced CMO Model, Terminates Executive
9M ago
8K
PULM
Pulmatrix to Present at Investor Conferences, Limits Updates
PremiumCompany Announcements
Pulmatrix to Present at Investor Conferences, Limits Updates
9M ago
8K
PULM
Pulmatrix to stop patient enrollment of the Ph2b study of PUR1900
PremiumThe Fly
Pulmatrix to stop patient enrollment of the Ph2b study of PUR1900
11M ago
PULM
Pulmatrix’s IND application for PUR3100 to treat acute migraine accepted by FDA
PremiumThe Fly
Pulmatrix’s IND application for PUR3100 to treat acute migraine accepted by FDA
1y ago
PULM
Pulmatrix submits NDA to FDA to initiate Phase 2 trial of PUR3100
PremiumThe FlyPulmatrix submits NDA to FDA to initiate Phase 2 trial of PUR3100
1y ago
PULM
Pulmatrix to present Phase 1 data of PUR3100 in acute migraine
Premium
The Fly
Pulmatrix to present Phase 1 data of PUR3100 in acute migraine
1y ago
PULM
Pulmatrix reports Q4 revenue $6.1M vs. $5.2M last year
Premium
The Fly
Pulmatrix reports Q4 revenue $6.1M vs. $5.2M last year
2y ago
PULM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >